- AVTX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Avalo Therapeutics (AVTX) S-3Shelf registration
Filed: 8 Nov 16, 12:00am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Cerecor Inc. for the registration of up to $75 million of common stock, preferred stock, debt securities, and warrants, and to the incorporation by reference therein of our report dated March 23, 2016, with respect to the financial statements of Cerecor Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2015, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Baltimore, Maryland
November 8, 2016
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.